{
  "variants": [
    {
      "gene": "PARK2",
      "protein_change": "K27N",
      "variant_string": "PARK2_K27N",
      "functional_evidence": {
        "aim": "Pathogenic",
        "acmg_flowchart": {
          "step_1": {
            "definition": "AR-JP caused by Parkin mutations disrupting Rpn10 interaction",
            "applicable": true,
            "reason": "Structural changes in Parkin affect proteasome function"
          },
          "step_2": {
            "assay_type": "X-ray crystallography and MD simulations",
            "applicable": true,
            "reason": "Structural assays directly assess functional disruption"
          },
          "step_3": {
            "controls_used": {
              "wild_type": true,
              "replicates": false,
              "known_variants": false
            },
            "assay_validity": "Max PS3_supporting",
            "reason": "X-ray/MD are standard methods; no replicates or variant controls mentioned"
          },
          "step_4": {
            "statistical_analysis": {
              "odds_path": null,
              "controls_total": 5,
              "evidence_strength": "PS3_supporting",
              "reason": "Fewer than 11 controls; structural changes align with pathogenic mechanism"
            }
          }
        }
      }
    },
    {
      "gene": "PARK2",
      "protein_change": "R33Q",
      "variant_string": "PARK2_R33Q",
      "functional_evidence": {
        "aim": "Pathogenic",
        "acmg_flowchart": {
          "step_1": {
            "definition": "AR-JP caused by Parkin mutations disrupting Rpn10 interaction",
            "applicable": true,
            "reason": "Structural changes in Parkin affect proteasome function"
          },
          "step_2": {
            "assay_type": "X-ray crystallography and MD simulations",
            "applicable": true,
            "reason": "Structural assays directly assess functional disruption"
          },
          "step_3": {
            "controls_used": {
              "wild_type": true,
              "replicates": false,
              "known_variants": false
            },
            "assay_validity": "Max PS3_supporting",
            "reason": "X-ray/MD are standard methods; no replicates or variant controls mentioned"
          },
          "step_4": {
            "statistical_analysis": {
              "odds_path": null,
              "controls_total": 5,
              "evidence_strength": "PS3_supporting",
              "reason": "Fewer than 11 controls; structural changes align with pathogenic mechanism"
            }
          }
        }
      }
    },
    {
      "gene": "PARK2",
      "protein_change": "R42P",
      "variant_string": "PARK2_R42P",
      "functional_evidence": {
        "aim": "Pathogenic",
        "acmg_flowchart": {
          "step_1": {
            "definition": "AR-JP caused by Parkin mutations disrupting Rpn10 interaction",
            "applicable": true,
            "reason": "Structural changes in Parkin affect proteasome function"
          },
          "step_2": {
            "assay_type": "X-ray crystallography and MD simulations",
            "applicable": true,
            "reason": "Structural assays directly assess functional disruption"
          },
          "step_3": {
            "controls_used": {
              "wild_type": true,
              "replicates": false,
              "known_variants": false
            },
            "assay_validity": "Max PS3_supporting",
            "reason": "X-ray/MD are standard methods; no replicates or variant controls mentioned"
          },
          "step_4": {
            "statistical_analysis": {
              "odds_path": null,
              "controls_total": 5,
              "evidence_strength": "PS3_supporting",
              "reason": "Fewer than 11 controls; structural changes align with pathogenic mechanism"
            }
          }
        }
      }
    },
    {
      "gene": "PARK2",
      "protein_change": "V56E",
      "variant_string": "PARK2_V56E",
      "functional_evidence": {
        "aim": "Pathogenic",
        "acmg_flowchart": {
          "step_1": {
            "definition": "AR-JP caused by Parkin mutations disrupting Rpn10 interaction",
            "applicable": true,
            "reason": "Structural changes in Parkin affect proteasome function"
          },
          "step_2": {
            "assay_type": "X-ray crystallography and MD simulations",
            "applicable": true,
            "reason": "Structural assays directly assess functional disruption"
          },
          "step_3": {
            "controls_used": {
              "wild_type": true,
              "replicates": false,
              "known_variants": false
            },
            "assay_validity": "Max PS3_supporting",
            "reason": "X-ray/MD are standard methods; no replicates or variant controls mentioned"
          },
          "step_4": {
            "statistical_analysis": {
              "odds_path": null,
              "controls_total": 5,
              "evidence_strength": "PS3_supporting",
              "reason": "Fewer than 11 controls; structural changes align with pathogenic mechanism"
            }
          }
        }
      }
    },
    {
      "gene": "PARK2",
      "protein_change": "K48A",
      "variant_string": "PARK2_K48A",
      "functional_evidence": {
        "aim": "Not applicable",
        "acmg_flowchart": {
          "step_1": {
            "definition": "AR-JP caused by Parkin mutations disrupting Rpn10 interaction",
            "applicable": true,
            "reason": "Structural changes in Parkin affect proteasome function"
          },
          "step_2": {
            "assay_type": "X-ray crystallography and MD simulations",
            "applicable": true,
            "reason": "Structural assays directly assess functional disruption"
          },
          "step_3": {
            "controls_used": {
              "wild_type": true,
              "replicates": false,
              "known_variants": false
            },
            "assay_validity": "N/A",
            "reason": "No functional data provided in the abstract"
          },
          "step_4": {
            "statistical_analysis": {
              "odds_path": null,
              "controls_total": 0,
              "evidence_strength": "N/A",
              "reason": "No functional data provided in the abstract"
            }
          }
        }
      }
    }
  ]
}